Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-18-025141
Date:2018-04-17
Issuer: INSYS THERAPEUTICS, INC. (INSY)
Original Submission Date:

Reporting Person:

MOTAHARI SAEED
C/O INSYS THERAPEUTICS, INC.
1333 SOUTH SPECTRUM BLVD, SUITE 100 CHANDLER, AZ 85286

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2018-04-17 A 11,000 a $0.00 26,400 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2018-04-17 deemed execution date D 11,000 (d) common stock 11,000 $0.00 22,000 direct
Footnotes
IDfootnote
f1 each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
f2 on april 17, 2017, the reporting person received a 33,000 share restricted stock unit award ("rsus"). the rsus vest in 3 equal annual installments beginning on april 17, 2018 and will be fully vested on april 17, 2020, in all cases so long as there has been no break in the reporting person's continuous service through such date.
WhaleWisdom Logo

Elevate your investments